Roche Holding AG (RHHBF)
OTCMKTS · Delayed Price · Currency is USD
425.00
+5.00 (1.19%)
At close: Dec 23, 2025
Roche Holding AG Market Cap
Roche Holding AG has a market cap or net worth of $356.6 billion as of December 24, 2025. Its market cap has increased by 52.33% in one year.
Market Cap
356.60B
Enterprise Value
390.78B
Revenue
79.83B
Ranking
n/a
PE Ratio
30.08
Stock Price
$425.00
Market Cap Chart
Since January 2, 1992, Roche Holding AG's market cap has increased from 8.76B to 356.60B, an increase of 3,971.42%. That is a compound annual growth rate of 11.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 356.60B | 57.63% |
| Dec 30, 2024 | 226.23B | -3.34% |
| Dec 29, 2023 | 234.04B | -9.76% |
| Dec 30, 2022 | 259.35B | -22.73% |
| Dec 30, 2021 | 335.62B | 12.23% |
| Dec 30, 2020 | 299.05B | 8.13% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 820.05M |
| Glass House Brands | 755.14M |
| Elite Pharmaceuticals | 521.60M |
| Northwest Biotherapeutics | 395.14M |
| CytoDyn | 358.49M |
| Silence Therapeutics | 300.88M |
| Nika Pharmaceuticals | 291.10M |
| American Oncology Network | 190.62M |